samuel cohen

intro’d to Samuel via his 2015 ted at bcg london – Alzheimer’s is not normal aging — and we can cure it

114 yrs.. no advancement in alzheimer’s research.. tangles in brain

working to find cure for over a decade.. now effects 40 mill people world wide . .. but by 2050 will effect 150 mill people…

if live 85 or older.. chance of getting alz almost 1 in 2..

in u.s. alz care costs 200 bill dollars every year.. 1 in 5 medicare dollars on alz.. today.. the most expensive disease.. and expected to increase 5 fold by 2050… alz is on of biggest medical/social challenges of our generation.. but little to address it

today.. of top 10 causes of death world wide.. alz is only one we can’t prevent/cure or even slow down.. invested less time/money researching..

3 min – u.s. spends 10 times more on cancer research.. despite fact that alz costs more and causes similar deaths.. [cancer research: 5 bn, alz: .5 bn; cancer cost: 100 bn, alz: 200 bn; cancer deaths: 550k, alz: 500k]

lack of resources from more fundamental cause.. lack of awareness.. few people know that alz is a disease and we can cure it..

for past 114 yrs mistakenly mistaken alz with aging.. damage caused by alz.. significantly reduces life expectancy…

today.. know tangles are made from protein molecules.. sticky bits end up on outside… forming clumps… that become the tangles..

spent last 10 yrs.. at cambridge .. trying to understand this malfunction… till recently.. cutting wires and hoping for best… but recently.. now testing new class of drugs..

finally real hope.. but to grow it.. we need help.. not about scientists.. about you.. raise awareness that it’s a disease..  patients putting pressure.. to advance treatment.. for ie: hiv, cancer, … but alz patients unable to speak up for selves.. and family too tired..

not a genetic disease… everyone with a brain is at risk

______

find/follow Samuel:

https://www.ted.com/speakers/samuel_cohen

Samuel Cohen is a Research Fellow in Biophysical Chemistry at St. John’s College and the Centre for Misfolding Diseases in the Department of Chemistry at the University of Cambridge, from where he holds PhD, MSci, MA and BA degrees. Cohen has worked as a consultant in the London office of Boston Consulting Group (BCG), where he specialized in the healthcare, technology and media sectors. His scientific research focuses on neurodegenerative disorders. He is co-author of more than 20 scientific papers, book chapters and patents, and was recently a lead author on a widely-reported study in which researchers made a major breakthrough towards finding a cure for Alzheimer’s disease.

_________

musicophilia et al